Biotech Funds: Enter With Care
They're expensive, managers have less-than-stellar records, and they invest in the same stocks.
09:34AM 07/27/06
Some Biotech Mutual Funds Worth Considering
Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.
07:31AM 11/21/01
Weekly Scorecard: This Week's Mutual Fund Winners and Losers
How the best, worst and biggest mutual funds did; also, the sector scorecard.
12:25PM 02/03/01
Weekly Scorecard: This Week's Mutual Fund Winners and Losers
How the best, worst and biggest mutual funds did; also, the sector scorecard.
11:27AM 08/26/00
Weekly Scorecard: This Week's Mutual Fund Winners and Losers
How the best, worst and biggest mutual funds performed; also, check out the sector fund scorecard and stock in the spotlight.
10:35AM 07/08/00
How this week's best, worst, and biggest funds performed; also, check out the Sector Fund Scorecard and Stock in the Spotlight.
10:45AM 06/24/00
Flood of Assets Pushes Fidelity Biotech Fund Into Uncharted Territory
Can the fund absorb billions in new cash and continue to perform?
12:51PM 04/03/00
Same Song, New Verse: Hot Money Arrives Late for Biotech Party
Despite Wednesday's rally, it appears many latecomers are underwater on their biotech fund investments.
08:00PM 03/22/00
Saturday Screen: In Biotech, Bigger Isn't Always Better
Most billion-dollar health care mutual funds aren't getting as much of a pop from the biotech boom.
10:28AM 02/12/00



Connect with TheStreet